Hemosiderosis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Line 17: | Line 17: | ||
==Prognosis== | ==Prognosis== | ||
*Prognosis is generally variable | |||
*The mean survival rate of patients with [[IPH]] is 2.5 to 5 years after diagnosis. | |||
*Deaths can occur from acute massive [[hemorrhage]] or after progressive [[pulmonary insufficiency]] and [[right heart failure]]. | |||
==References== | ==References== |
Revision as of 07:51, 28 September 2020
Hemosiderosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemosiderosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Hemosiderosis natural history, complications and prognosis |
FDA on Hemosiderosis natural history, complications and prognosis |
CDC on Hemosiderosis natural history, complications and prognosis |
Hemosiderosis natural history, complications and prognosis in the news |
Blogs on Hemosiderosis natural history, complications and prognosis |
Risk calculators and risk factors for Hemosiderosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
- The clinical spectrum of IPH ranges from asymptomatic cases to a chronic cough and dyspnea to repetitive hemoptysis with fatigue, anemia, and slowly progressive dyspnea and life-threatening acute respiratory failure.
- Common complications of IPH include Iron deficiency anemia and pulmonary fibrosis.
- Prognosis is generally variable, and the mean survival rate of patients with IPH is 2.5 to 5 years after diagnosis. Deaths can occur from acute massive hemorrhage or after progressive pulmonary insufficiency and right heart failure.
Natural History
- The clinical spectrum of IPH ranges from asymptomatic cases to a chronic cough and dyspnea to repetitive hemoptysis with fatigue, anemia, and slowly progressive dyspnea and life-threatening acute respiratory failure.
Complications
- Common complications of IPH include:
- Iron deficiency anemia
- Pulmonary fibrosis
Prognosis
- Prognosis is generally variable
- The mean survival rate of patients with IPH is 2.5 to 5 years after diagnosis.
- Deaths can occur from acute massive hemorrhage or after progressive pulmonary insufficiency and right heart failure.